Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
83
LFSC Quote, Financials, Valuation and Earnings
Last price:
$38.00
Seasonality move
:
0.9%
Day range:
$37.51 - $37.92
52-week range:
$18.78 - $37.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
4.7K
Avg. volume:
6.4K
1-year change:
44.58%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
LFSC
F/m Emerald Life Sciences Innovation ETF
|
-- | -- | -- | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | -- | -- | -- | -- |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
-- | -- | -- | -- | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | -- | -- | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | -- | -- | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
LFSC
F/m Emerald Life Sciences Innovation ETF
|
$37.91 | -- | -- | -- | $0.00 | 0% | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
$79.36 | -- | -- | -- | $0.00 | 0% | -- |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
$28.74 | -- | -- | -- | $0.10 | 0.79% | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
$45.70 | -- | -- | -- | $0.00 | 0.08% | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
$53.59 | -- | -- | -- | $0.03 | 0% | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
$50.15 | -- | -- | -- | $1.17 | 2.34% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
LFSC
F/m Emerald Life Sciences Innovation ETF
|
-- | 1.835 | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | 0.818 | -- | -- |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
-- | 0.819 | -- | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | 0.727 | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | 1.024 | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | 1.453 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
LFSC
F/m Emerald Life Sciences Innovation ETF
|
-- | -- | -- | -- | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | -- | -- | -- | -- | -- |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | -- | -- | -- | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | -- | -- | -- | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | -- | -- | -- | -- | -- |
F/m Emerald Life Sciences Innovation ETF vs. Competitors
-
Which has Higher Returns LFSC or BBP?
Virtus LifeSci Biotech Products ETF has a net margin of -- compared to F/m Emerald Life Sciences Innovation ETF's net margin of --. F/m Emerald Life Sciences Innovation ETF's return on equity of -- beat Virtus LifeSci Biotech Products ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LFSCF/m Emerald Life Sciences Innovation ETF-- -- -- BBPVirtus LifeSci Biotech Products ETF-- -- -- -
What do Analysts Say About LFSC or BBP?
F/m Emerald Life Sciences Innovation ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Virtus LifeSci Biotech Products ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that F/m Emerald Life Sciences Innovation ETF has higher upside potential than Virtus LifeSci Biotech Products ETF, analysts believe F/m Emerald Life Sciences Innovation ETF is more attractive than Virtus LifeSci Biotech Products ETF.
Company Buy Ratings Hold Ratings Sell Ratings LFSCF/m Emerald Life Sciences Innovation ETF0 0 0 BBPVirtus LifeSci Biotech Products ETF0 0 0 -
Is LFSC or BBP More Risky?
F/m Emerald Life Sciences Innovation ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Virtus LifeSci Biotech Products ETF has a beta of 0.640, suggesting its less volatile than the S&P 500 by 35.974%.
-
Which is a Better Dividend Stock LFSC or BBP?
F/m Emerald Life Sciences Innovation ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Virtus LifeSci Biotech Products ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. F/m Emerald Life Sciences Innovation ETF pays -- of its earnings as a dividend. Virtus LifeSci Biotech Products ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LFSC or BBP?
F/m Emerald Life Sciences Innovation ETF quarterly revenues are --, which are smaller than Virtus LifeSci Biotech Products ETF quarterly revenues of --. F/m Emerald Life Sciences Innovation ETF's net income of -- is lower than Virtus LifeSci Biotech Products ETF's net income of --. Notably, F/m Emerald Life Sciences Innovation ETF's price-to-earnings ratio is -- while Virtus LifeSci Biotech Products ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for F/m Emerald Life Sciences Innovation ETF is -- versus -- for Virtus LifeSci Biotech Products ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFSCF/m Emerald Life Sciences Innovation ETF-- -- -- -- BBPVirtus LifeSci Biotech Products ETF-- -- -- --
-
Which has Higher Returns LFSC or IBBQ?
Invesco Nasdaq Biotechnology ETF has a net margin of -- compared to F/m Emerald Life Sciences Innovation ETF's net margin of --. F/m Emerald Life Sciences Innovation ETF's return on equity of -- beat Invesco Nasdaq Biotechnology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LFSCF/m Emerald Life Sciences Innovation ETF-- -- -- IBBQInvesco Nasdaq Biotechnology ETF-- -- -- -
What do Analysts Say About LFSC or IBBQ?
F/m Emerald Life Sciences Innovation ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Nasdaq Biotechnology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that F/m Emerald Life Sciences Innovation ETF has higher upside potential than Invesco Nasdaq Biotechnology ETF, analysts believe F/m Emerald Life Sciences Innovation ETF is more attractive than Invesco Nasdaq Biotechnology ETF.
Company Buy Ratings Hold Ratings Sell Ratings LFSCF/m Emerald Life Sciences Innovation ETF0 0 0 IBBQInvesco Nasdaq Biotechnology ETF0 0 0 -
Is LFSC or IBBQ More Risky?
F/m Emerald Life Sciences Innovation ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Invesco Nasdaq Biotechnology ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock LFSC or IBBQ?
F/m Emerald Life Sciences Innovation ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Invesco Nasdaq Biotechnology ETF offers a yield of 0.79% to investors and pays a quarterly dividend of $0.10 per share. F/m Emerald Life Sciences Innovation ETF pays -- of its earnings as a dividend. Invesco Nasdaq Biotechnology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LFSC or IBBQ?
F/m Emerald Life Sciences Innovation ETF quarterly revenues are --, which are smaller than Invesco Nasdaq Biotechnology ETF quarterly revenues of --. F/m Emerald Life Sciences Innovation ETF's net income of -- is lower than Invesco Nasdaq Biotechnology ETF's net income of --. Notably, F/m Emerald Life Sciences Innovation ETF's price-to-earnings ratio is -- while Invesco Nasdaq Biotechnology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for F/m Emerald Life Sciences Innovation ETF is -- versus -- for Invesco Nasdaq Biotechnology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFSCF/m Emerald Life Sciences Innovation ETF-- -- -- -- IBBQInvesco Nasdaq Biotechnology ETF-- -- -- --
-
Which has Higher Returns LFSC or PSCH?
Invesco S&P SmallCap Health Care ETF has a net margin of -- compared to F/m Emerald Life Sciences Innovation ETF's net margin of --. F/m Emerald Life Sciences Innovation ETF's return on equity of -- beat Invesco S&P SmallCap Health Care ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LFSCF/m Emerald Life Sciences Innovation ETF-- -- -- PSCHInvesco S&P SmallCap Health Care ETF-- -- -- -
What do Analysts Say About LFSC or PSCH?
F/m Emerald Life Sciences Innovation ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco S&P SmallCap Health Care ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that F/m Emerald Life Sciences Innovation ETF has higher upside potential than Invesco S&P SmallCap Health Care ETF, analysts believe F/m Emerald Life Sciences Innovation ETF is more attractive than Invesco S&P SmallCap Health Care ETF.
Company Buy Ratings Hold Ratings Sell Ratings LFSCF/m Emerald Life Sciences Innovation ETF0 0 0 PSCHInvesco S&P SmallCap Health Care ETF0 0 0 -
Is LFSC or PSCH More Risky?
F/m Emerald Life Sciences Innovation ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Invesco S&P SmallCap Health Care ETF has a beta of 0.945, suggesting its less volatile than the S&P 500 by 5.48%.
-
Which is a Better Dividend Stock LFSC or PSCH?
F/m Emerald Life Sciences Innovation ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Invesco S&P SmallCap Health Care ETF offers a yield of 0.08% to investors and pays a quarterly dividend of $0.00 per share. F/m Emerald Life Sciences Innovation ETF pays -- of its earnings as a dividend. Invesco S&P SmallCap Health Care ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LFSC or PSCH?
F/m Emerald Life Sciences Innovation ETF quarterly revenues are --, which are smaller than Invesco S&P SmallCap Health Care ETF quarterly revenues of --. F/m Emerald Life Sciences Innovation ETF's net income of -- is lower than Invesco S&P SmallCap Health Care ETF's net income of --. Notably, F/m Emerald Life Sciences Innovation ETF's price-to-earnings ratio is -- while Invesco S&P SmallCap Health Care ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for F/m Emerald Life Sciences Innovation ETF is -- versus -- for Invesco S&P SmallCap Health Care ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFSCF/m Emerald Life Sciences Innovation ETF-- -- -- -- PSCHInvesco S&P SmallCap Health Care ETF-- -- -- --
-
Which has Higher Returns LFSC or PTH?
Invesco Dorsey Wright Healthcare Momentum ETF has a net margin of -- compared to F/m Emerald Life Sciences Innovation ETF's net margin of --. F/m Emerald Life Sciences Innovation ETF's return on equity of -- beat Invesco Dorsey Wright Healthcare Momentum ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LFSCF/m Emerald Life Sciences Innovation ETF-- -- -- PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- -
What do Analysts Say About LFSC or PTH?
F/m Emerald Life Sciences Innovation ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Dorsey Wright Healthcare Momentum ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that F/m Emerald Life Sciences Innovation ETF has higher upside potential than Invesco Dorsey Wright Healthcare Momentum ETF, analysts believe F/m Emerald Life Sciences Innovation ETF is more attractive than Invesco Dorsey Wright Healthcare Momentum ETF.
Company Buy Ratings Hold Ratings Sell Ratings LFSCF/m Emerald Life Sciences Innovation ETF0 0 0 PTHInvesco Dorsey Wright Healthcare Momentum ETF0 0 0 -
Is LFSC or PTH More Risky?
F/m Emerald Life Sciences Innovation ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Invesco Dorsey Wright Healthcare Momentum ETF has a beta of 0.943, suggesting its less volatile than the S&P 500 by 5.68%.
-
Which is a Better Dividend Stock LFSC or PTH?
F/m Emerald Life Sciences Innovation ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Invesco Dorsey Wright Healthcare Momentum ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.03 per share. F/m Emerald Life Sciences Innovation ETF pays -- of its earnings as a dividend. Invesco Dorsey Wright Healthcare Momentum ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LFSC or PTH?
F/m Emerald Life Sciences Innovation ETF quarterly revenues are --, which are smaller than Invesco Dorsey Wright Healthcare Momentum ETF quarterly revenues of --. F/m Emerald Life Sciences Innovation ETF's net income of -- is lower than Invesco Dorsey Wright Healthcare Momentum ETF's net income of --. Notably, F/m Emerald Life Sciences Innovation ETF's price-to-earnings ratio is -- while Invesco Dorsey Wright Healthcare Momentum ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for F/m Emerald Life Sciences Innovation ETF is -- versus -- for Invesco Dorsey Wright Healthcare Momentum ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFSCF/m Emerald Life Sciences Innovation ETF-- -- -- -- PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- --
-
Which has Higher Returns LFSC or SBIO?
ALPS Medical Breakthroughs ETF has a net margin of -- compared to F/m Emerald Life Sciences Innovation ETF's net margin of --. F/m Emerald Life Sciences Innovation ETF's return on equity of -- beat ALPS Medical Breakthroughs ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LFSCF/m Emerald Life Sciences Innovation ETF-- -- -- SBIOALPS Medical Breakthroughs ETF-- -- -- -
What do Analysts Say About LFSC or SBIO?
F/m Emerald Life Sciences Innovation ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ALPS Medical Breakthroughs ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that F/m Emerald Life Sciences Innovation ETF has higher upside potential than ALPS Medical Breakthroughs ETF, analysts believe F/m Emerald Life Sciences Innovation ETF is more attractive than ALPS Medical Breakthroughs ETF.
Company Buy Ratings Hold Ratings Sell Ratings LFSCF/m Emerald Life Sciences Innovation ETF0 0 0 SBIOALPS Medical Breakthroughs ETF0 0 0 -
Is LFSC or SBIO More Risky?
F/m Emerald Life Sciences Innovation ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison ALPS Medical Breakthroughs ETF has a beta of 0.849, suggesting its less volatile than the S&P 500 by 15.057%.
-
Which is a Better Dividend Stock LFSC or SBIO?
F/m Emerald Life Sciences Innovation ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ALPS Medical Breakthroughs ETF offers a yield of 2.34% to investors and pays a quarterly dividend of $1.17 per share. F/m Emerald Life Sciences Innovation ETF pays -- of its earnings as a dividend. ALPS Medical Breakthroughs ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LFSC or SBIO?
F/m Emerald Life Sciences Innovation ETF quarterly revenues are --, which are smaller than ALPS Medical Breakthroughs ETF quarterly revenues of --. F/m Emerald Life Sciences Innovation ETF's net income of -- is lower than ALPS Medical Breakthroughs ETF's net income of --. Notably, F/m Emerald Life Sciences Innovation ETF's price-to-earnings ratio is -- while ALPS Medical Breakthroughs ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for F/m Emerald Life Sciences Innovation ETF is -- versus -- for ALPS Medical Breakthroughs ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFSCF/m Emerald Life Sciences Innovation ETF-- -- -- -- SBIOALPS Medical Breakthroughs ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Buy
54
SMX alert for Dec 5
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Sell
15
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 0.06% over the past day.
Buy
67
NUTX alert for Dec 5
Nutex Health, Inc. [NUTX] is up 2.97% over the past day.
